Working to Eradicate Gynecologic Cancers

444
A state by state analysis of BRCA1 and BRCA2 testing in patients with ovarian cancer

Sunday, March 29, 2015: 7:00 AM
Salon C-D (Hilton Chicago)
T. J. Herzog1, J. Saam2, C. Arnell2 and R. J. Wenstrup2
1University of Cincinnati, Cincinnati, OH, 2Myriad Genetic Laboratories, Inc., Salt Lake City, UT